← All trials
NCT06055179
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2024
- Primary completion
- Dec 1, 2024
- Completion date
- Feb 1, 2025
- First posted
- Sep 26, 2023
- Last posted
- Dec 27, 2023
- Enrollment
- 98
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Guangzhou UniversityLead sponsor
- Guangdong Provincial Hospital of Traditional Chinese MedicineOverall official - principal investigator
- University of HoustonCollaborator
- Guangzhou UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.